{"ticker": {"uuid": "d7672096-f808-4c9f-a2d3-510aafa3ba44", "symbol": "SGHT", "name": "Sight Sciences Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Medical Devices"}, "articles": [{"title": "Reflecting On Medical Devices & Supplies - Specialty Stocks\u2019 Q1 Earnings: Integer Holdings (NYSE:ITGR)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxNUFd1SUpRcWlCdEFjU1YzNTZkdjBfRkwyY2lBYjh1ZXZlZTlyVlpWSWx1bExvckFrNHNhUEdVTGNFWUxaMkVDZUV2c2hPS1h2YVhNSHNsVzFYNUFrNHBnRVM1STRsa2Zmb0VXeEQ4UFRGNDBOWXZfWVU5VFUyQ3JZZm9KamZMWXVDSEtNMWwyVktpaEZfRjVNU1BYaWJ3NnpNUmRyMEpsSzBXdw?oc=5", "source_name": "Market source", "published_at": "2026-07-14T18:07:11+00:00", "published_display": "14 Jul 2026 18:07", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Have Insiders Sold Sight Sciences Shares Recently?", "summary": "Sight Sciences Co-Founder Paul Badawi recently sold US$155k worth of shares at US$5.42, which was 0.5% of his holding. While this sale, and a previous larger one at a higher price, indicates more insider selling than buying over the last year, the stock was sold above the current", "url": "https://simplywall.st/stocks/us/healthcare/nasdaq-sght/sight-sciences/news/have-insiders-sold-sight-sciences-shares-recently", "source_name": "Simply Wall Street", "published_at": "2026-07-09T10:49:02", "published_display": "09 Jul 2026 10:49", "sentiment": "negative", "sentiment_pct": 40, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Citi Maintains Sight Sciences(SGHT.US) With Hold Rating, Raises Target Price to $6", "summary": "Citi has reiterated its Hold rating for Sight Sciences (SGHT.US), increasing the target price for the company's stock to $6. This updated target indicates Citi's revised valuation for the medical device company.", "url": "https://www.moomoo.com/news/post/72646288/citi-maintains-sight-sciences-sghtus-with-hold-rating-raises-target", "source_name": "Moomoo", "published_at": "2026-07-08T21:12:39", "published_display": "08 Jul 2026 21:12", "sentiment": "positive", "sentiment_pct": 70, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Sight Sciences Inc focuses on glaucoma devices as investors watch Nasdaq trading", "summary": "Sight Sciences Inc is a US-based medical technology company specializing in devices for glaucoma and dry eye treatment, with its shares listed on Nasdaq. The company\u2019s strategy focuses on developing minimally invasive solutions to address chronic eye conditions in a growing ophth", "url": "https://www.ad-hoc-news.de/boerse/news/ueberblick/sight-sciences-inc-focuses-on-glaucoma-devices-as-investors-watch-nasdaq/69726297", "source_name": "AD HOC NEWS", "published_at": "2026-07-08T18:40:18", "published_display": "08 Jul 2026 18:40", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Form 4 Sight Sciences Inc For: 6 July By Investing.com", "summary": "This article from Investing.com announces the filing of Form 4 for Sight Sciences Inc. on July 6. It also includes general market data, news headlines, and various financial statistics as supplementary content. The core purpose of the article is to report on the Form 4 filing.", "url": "https://uk.investing.com/news/stock-market-news/form-4-sight-sciences-inc-for-6-july-93CH-4758634", "source_name": "Investing.com UK", "published_at": "2026-07-07T23:11:14", "published_display": "07 Jul 2026 23:11", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Sight Sciences (NASDAQ: SGHT) CFO sells 6,902 shares to cover RSU tax bill", "summary": "Sight Sciences CFO James Rodberg sold 6,902 shares of common stock on July 2, 2026, at a weighted average price of $5.36 per share. The sale was conducted to cover tax obligations related to the vesting of his restricted stock units (RSUs). Following this transaction, Rodberg ret", "url": "https://www.stocktitan.net/sec-filings/SGHT/form-4-sight-sciences-inc-insider-trading-activity-b49fe6614591.html", "source_name": "Stock Titan", "published_at": "2026-07-07T20:49:03", "published_display": "07 Jul 2026 20:49", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Sight Sciences CLO Jeremy Hayden sells $70,133 in stock", "summary": "Jeremy Hayden, CLO at Sight Sciences (NASDAQ:SGHT), sold 12,733 shares for $70,133 to cover tax liabilities associated with restricted stock units. Despite this insider sale, Hayden still directly holds 357,037 shares. Investing.com analysis suggests the stock is currently overva", "url": "https://www.investing.com/news/insider-trading-news/sight-sciences-clo-jeremy-hayden-sells-70133-in-stock-93CH-4778033", "source_name": "Investing.com", "published_at": "2026-07-07T20:49:03", "published_display": "07 Jul 2026 20:49", "sentiment": "negative", "sentiment_pct": 37, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Form 144 Sight Sciences For: 6 July By Investing.com", "summary": "This article from Investing.com briefly notes the filing of Form 144 for Sight Sciences (SGHT) on July 6. The content is primarily a placeholder for this financial reporting and includes various market data, news headlines, and related financial information, but no further detail", "url": "https://ng.investing.com/news/stock-market-news/form-144-sight-sciences-for-6-july-93CH-2587958", "source_name": "Investing.com Nigeria", "published_at": "2026-07-07T20:40:18", "published_display": "07 Jul 2026 20:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price to earnings forward of Sight Sciences, Inc. \u2013 NASDAQ:SGHT", "summary": "This article provides financial information for Sight Sciences, Inc. (NASDAQ: SGHT), specifically focusing on its price-to-earnings forward ratio. The content appears to be a stub or an incomplete data point from a financial platform like TradingView, as it lacks detailed analyti", "url": "https://www.tradingview.com/symbols/NASDAQ-SGHT/financials-statistics-and-ratios/price-earnings-fwd/", "source_name": "TradingView", "published_at": "2026-07-07T10:12:53", "published_display": "07 Jul 2026 10:12", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Sight Sciences CFO James Rodberg sells $36,994 in common shares", "summary": "Sight Sciences CFO James Rodberg sold 6,902 common shares worth $36,994 to cover tax liabilities from vesting stock units. Following the transaction, Rodberg directly holds 224,037 shares. The company recently reported mixed Q1 2026 earnings, exceeding revenue expectations but mi", "url": "https://www.investing.com/news/insider-trading-news/sight-sciences-cfo-james-rodberg-sells-36994-in-common-shares-93CH-4778032", "source_name": "Investing.com", "published_at": "2026-07-07T09:40:20", "published_display": "07 Jul 2026 09:40", "sentiment": "negative", "sentiment_pct": 39, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Sight Sciences (SGHT) EVP sells shares to cover RSU-related tax obligations", "summary": "Taylor Brenton, EVP of Operations & R&D at Sight Sciences (SGHT), sold 2,829 shares of company stock at a weighted average price of $5.42 per share. This sale, totaling $15,333, was primarily to cover tax obligations arising from the vesting of restricted stock units (RSUs) rathe", "url": "https://www.stocktitan.net/sec-filings/SGHT/form-4-sight-sciences-inc-insider-trading-activity-0de92e5ce41b.html", "source_name": "Stock Titan", "published_at": "2026-07-07T08:11:15", "published_display": "07 Jul 2026 08:11", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Sight Sciences CFO James Rodberg sells $36,994 in common shares By Investing.com", "summary": "", "url": "https://news.google.com/rss/articles/CBMivwFBVV95cUxPTnM4YVdXSk81Q3IxZUY2TWtZZHpJazhXRkw3S1RFYlEyTjc4bkRhdHpZN1MtT0RCY0Z5R0V6dklCLWNkVzJ1NGowVXlsenpaVUZnZHZpdEt6YWdJXzhuWFNoaTdNSE9JcUFHS3VoUXotN0JTcU0tYWhPOWNWSGdobVJhRWRFZ2V4SS1DU0E0MFRrQ2Y0UEc4UUdhaFh5MW5JMjJKemVKT0RMamF4c3dRZm45aWhtUEFNN2d6TE14Zw?oc=5", "source_name": "Investing.com Nigeria", "published_at": "2026-07-07T00:04:22+00:00", "published_display": "07 Jul 2026 00:04", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Sight Sciences COO Alison Bauerlein sells $129,626 in stock By Investing.com", "summary": "Sight Sciences COO Alison Bauerlein sold 24,184 shares of company stock worth $129,626 to cover tax liabilities. Following the sale, she directly holds 664,709 shares. This transaction comes amidst mixed Q1 2026 earnings for Sight Sciences, where revenue beat expectations but EPS", "url": "https://m.za.investing.com/news/stock-market-news/sight-sciences-coo-alison-bauerlein-sells-129626-in-stock-93CH-4357436?ampMode=1", "source_name": "Investing.com South Africa", "published_at": "2026-07-07T00:11:14", "published_display": "07 Jul 2026 00:11", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 93, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Sight Sciences CLO Jeremy Hayden sells $70,133 in stock By Investing.com", "summary": "Jeremy B. Hayden, Chief Legal Officer at Sight Sciences, Inc. (NASDAQ:SGHT), sold 12,733 shares of company stock for $70,133 to cover tax liabilities. Following the sale, he still directly holds 357,037 shares, including unvested restricted stock units. This transaction comes aft", "url": "https://m.za.investing.com/news/stock-market-news/sight-sciences-clo-jeremy-hayden-sells-70133-in-stock-93CH-4357444?ampMode=1", "source_name": "Investing.com South Africa", "published_at": "2026-07-07T00:11:14", "published_display": "07 Jul 2026 00:11", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Sight Sciences (SGHT) COO sells shares to cover RSU tax, retains 664,709 stake", "summary": "Sight Sciences, Inc. COO Alison Bauerlein sold 24,184 shares of common stock at a weighted average price of $5.36 per share. This sale was conducted to cover tax liabilities stemming from the vesting of restricted stock units (RSUs). Following this transaction, Bauerlein still ho", "url": "https://www.stocktitan.net/sec-filings/SGHT/form-4-sight-sciences-inc-insider-trading-activity-3120a5661f2c.html", "source_name": "Stock Titan", "published_at": "2026-07-06T23:11:15", "published_display": "06 Jul 2026 23:11", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Sight Sciences CEO Paul Badawi disposes of $155,467 in stock By Investing.com", "summary": "Paul Badawi, President and CEO of Sight Sciences Inc. (NASDAQ:SGHT), sold 28,684 shares of the company's common stock for $155,467 on July 1, 2026, to cover tax liabilities related to restricted stock units. Following this transaction, Badawi directly holds over 6.1 million share", "url": "https://m.za.investing.com/news/stock-market-news/sight-sciences-ceo-paul-badawi-disposes-of-155467-in-stock-93CH-4357438?ampMode=1", "source_name": "Investing.com South Africa", "published_at": "2026-07-06T23:11:15", "published_display": "06 Jul 2026 23:11", "sentiment": "negative", "sentiment_pct": 39, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Sight Sciences (NASDAQ: SGHT) CLO sells 12,733 shares to cover RSU taxes", "summary": "Sight Sciences Chief Legal Officer Jeremy B. Hayden sold 12,733 shares of common stock at a weighted average price of $5.51 per share. This sale was explicitly made to cover tax liabilities arising from the vesting of restricted stock units (RSUs), rather than a discretionary red", "url": "https://www.stocktitan.net/sec-filings/SGHT/form-4-sight-sciences-inc-insider-trading-activity-f048f8d1103f.html", "source_name": "Stock Titan", "published_at": "2026-07-06T23:11:14", "published_display": "06 Jul 2026 23:11", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Sight Sciences (SGHT) CTO sells 7,418 shares to cover RSU tax liability", "summary": "Sight Sciences, Inc. Chief Technology Officer David Badawi sold 7,418 shares of common stock at a weighted average price of $5.508 per share to cover tax liabilities from restricted stock unit vesting. Following this transaction, Badawi still holds 1,982,872 shares, comprising co", "url": "https://www.stocktitan.net/sec-filings/SGHT/form-4-sight-sciences-inc-insider-trading-activity-4982eb9526cc.html", "source_name": "Stock Titan", "published_at": "2026-07-06T23:11:14", "published_display": "06 Jul 2026 23:11", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Sight Sciences (SGHT) CEO\u2019s 28,684-share tax sale and updated holdings", "summary": "Sight Sciences, Inc. President and CEO Paul Badawi sold 28,684 shares of common stock at a weighted average price of $5.42 per share. This sale was conducted to cover his tax liability arising from the vesting of restricted stock units (RSUs). After this transaction, Badawi still", "url": "https://www.stocktitan.net/sec-filings/SGHT/form-4-sight-sciences-inc-insider-trading-activity-4c44b164d00b.html", "source_name": "Stock Titan", "published_at": "2026-07-06T23:11:14", "published_display": "06 Jul 2026 23:11", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "[144] Sight Sciences, Inc. SEC Filing", "summary": "This article details a Form 144 SEC filing by Sight Sciences, Inc. (SGHT) concerning a proposed sale of securities. The filing indicates the sale of 7,418 common shares acquired via restricted stock vesting on June 30, 2026, with an approximate sale date of July 6, 2026, through ", "url": "https://www.stocktitan.net/sec-filings/SGHT/144-sight-sciences-inc-sec-filing-017eb01cabc7.html", "source_name": "Stock Titan", "published_at": "2026-07-06T21:12:53", "published_display": "06 Jul 2026 21:12", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Sight Sciences COO Alison Bauerlein sells $129,626 in stock", "summary": "Alison Bauerlein, COO of Sight Sciences, Inc. (NASDAQ:SGHT), sold 24,184 shares of company stock for approximately $129,626 to cover tax liabilities from vested restricted stock units. Following the sale, she directly holds 664,709 shares, including unvested RSUs. The company rec", "url": "https://www.investing.com/news/insider-trading-news/sight-sciences-coo-alison-bauerlein-sells-129626-in-stock-93CH-4778026", "source_name": "Investing.com", "published_at": "2026-07-06T09:40:20", "published_display": "06 Jul 2026 09:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Sight Sciences EVP Brenton Taylor sells $15,333 in company stock", "summary": "", "url": "https://news.google.com/rss/articles/CBMixgFBVV95cUxQREw1a3ptd2dmVXk4TS1XdE9vdngyT2FSbHZXaHlCMTNValZDaWRMcnk1TUVWTS1Uamt6Y3RrOGstNE5EekJzX1JiWkE2RDRpSGdJeENlOE1PZC1SdjlYWGhXb2xHSG5QWllvZlZoQWdNQTV0eFpNeXhVTW40NnBfYnN2ZHRNaHNNNUREUkQza0NPQjhBbE9wU2x4STJRaEd3aV9hMkxOaDRmTE13Yy02Mk5OSTZ5OVNWOUNoakkyVEFnOGZGU2c?oc=5", "source_name": "Investing.com", "published_at": "2026-07-06T07:00:00+00:00", "published_display": "06 Jul 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "SGHT (NASDAQ: SGHT) affiliate files Form 144 to sell 12,733 shares", "summary": "", "url": "https://news.google.com/rss/articles/CBMimwFBVV95cUxQcWpuLS0xbGR1d29hdEhFSGU1azdKSS0ybEdGUFdoNDZLYkJadkRLclFTVG9Wb1UwNENGazcza1NwMzhfVEgtczdaWFB4ZDlQLWZ4R1V4R0VaUTdSVzZNTzJHV0V6RDJvcHZpT21NV0ZWUWw3d2ZhVVk2TmtSNUMyWVotc2gzcUFJbFNXbEIxdzJZSml2ZTNFN2taRQ?oc=5", "source_name": "Stock Titan", "published_at": "2026-07-06T07:00:00+00:00", "published_display": "06 Jul 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Sight Sciences CTO David Badawi sells $40,858 in stock", "summary": "Sight Sciences CTO David Badawi sold 7,418 shares of the company's common stock for $40,858 to cover tax liabilities from restricted stock units. Following the sale, Badawi still holds a significant number of shares, including vested and unvested RSUs. InvestingPro analysis sugge", "url": "https://www.investing.com/news/insider-trading-news/sight-sciences-cto-david-badawi-sells-40858-in-stock-93CH-4778036", "source_name": "Investing.com", "published_at": "2026-07-06T07:39:00", "published_display": "06 Jul 2026 07:39", "sentiment": "negative", "sentiment_pct": 39, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price to book forward of Sight Sciences, Inc. \u2013 NASDAQ:SGHT", "summary": "This article displays the \"Price to book forward\" financial metric for Sight Sciences, Inc. (NASDAQ: SGHT). It presents the current value, change, and percentage change for this specific financial statistic. The content is presented by TradingView, sourcing data from ICE Data Ser", "url": "https://www.tradingview.com/symbols/NASDAQ-SGHT/financials-statistics-and-ratios/price-book-fwd/", "source_name": "TradingView", "published_at": "2026-07-05T13:40:49", "published_display": "05 Jul 2026 13:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Form 144 Sight Sciences For: 2 July By Investing.com", "summary": "This article announces the filing of Form 144 for Sight Sciences (SGHT) on July 2. Form 144 filings indicate an insider's intent to sell restricted stock. The brief piece reiterates the headline multiple times and includes a market data table.", "url": "https://ca.investing.com/news/stock-market-news/form-144-sight-sciences-for-2-july-93CH-4719350", "source_name": "Investing.com Canada", "published_at": "2026-07-02T22:39:18", "published_display": "02 Jul 2026 22:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "SGHT (NASDAQ) Form 144 shows 6,902-share resale after restricted-vesting", "summary": "Sight Sciences, Inc. (SGHT) filed a Form 144 notification indicating a proposed sale of 6,902 shares of common stock stemming from restricted stock vesting. The filing also disclosed 54,409,942 shares outstanding as of July 2, 2026, and reported a prior sale of 7,231 shares on Ap", "url": "https://www.stocktitan.net/sec-filings/SGHT/144-sight-sciences-inc-sec-filing-1c1b9a4cee3b.html", "source_name": "Stock Titan", "published_at": "2026-07-02T21:39:18", "published_display": "02 Jul 2026 21:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "SGHT (NASDAQ) insider resale notice: 24,184 shares tied to vesting", "summary": "Sight Sciences, Inc. (SGHT) filed a Form 144 notice disclosing the proposed resale of 24,184 shares of common stock associated with a restricted stock vesting event on June 30, 2026. The filing also detailed two prior open-market sales by an insider on April 2, 2026, and May 18, ", "url": "https://www.stocktitan.net/sec-filings/SGHT/144-sight-sciences-inc-sec-filing-3ed6c731940d.html", "source_name": "Stock Titan", "published_at": "2026-07-02T21:39:17", "published_display": "02 Jul 2026 21:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "2,829 Restricted Shares for SGHT (NASDAQ: SGHT) - Form 144 Notice", "summary": "A Form 144 notice has been filed for Sight Sciences, Inc. (NASDAQ: SGHT), indicating an intent to sell 2,829 shares of common stock stemming from restricted stock vesting. The event date for the vesting is June 30, 2026, with Fidelity Brokerage Services LLC listed as the broker. ", "url": "https://www.stocktitan.net/sec-filings/SGHT/144-sight-sciences-inc-sec-filing-c35be394a5d0.html", "source_name": "Stock Titan", "published_at": "2026-07-01T21:09:24", "published_display": "01 Jul 2026 21:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "SGHT (NASDAQ: SGHT) files notice for 28,684\u2011share restricted stock sale", "summary": "Sight Sciences, Inc. (NASDAQ: SGHT) has filed a Form 144 notice for the proposed sale of 28,684 shares of common stock resulting from restricted stock vesting on June 30, 2026. The filing also disclosed a previous sale by Paul Badawi of 29,244 shares on April 1, 2026, for $108,08", "url": "https://www.stocktitan.net/sec-filings/SGHT/144-sight-sciences-inc-sec-filing-6dd29bcc9626.html", "source_name": "Stock Titan", "published_at": "2026-07-01T21:09:24", "published_display": "01 Jul 2026 21:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Form 144 Sight Sciences For: 1 July By Investing.com", "summary": "This article from Investing.com reports on a Form 144 filing for Sight Sciences (SGHT) on July 1st. The brief piece indicates that SGHT's stock is up 0.37% and encourages readers to view comments, though none are present. It serves as a concise notification of the regulatory fili", "url": "https://ca.investing.com/news/stock-market-news/form-144-sight-sciences-for-1-july-93CH-4717094", "source_name": "Investing.com Canada", "published_at": "2026-07-01T21:09:24", "published_display": "01 Jul 2026 21:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Sight Sciences, Inc. Actuals & Estimates (NASDAQ:SGHT)", "summary": "Sight Sciences, Inc. (NASDAQ: SGHT) stock has seen significant increases recently, rising 4.21% in the past 24 hours, 11.13% over the last week, and 13.12% in the last month. Analysts have a wide forecast range for SGHT, with a max estimate of $12.00 and a min of $5.15. The compa", "url": "https://www.tradingview.com/symbols/NASDAQ-SGHT/forecast-actuals-and-estimates/", "source_name": "TradingView", "published_at": "2026-06-26T15:40:29", "published_display": "26 Jun 2026 15:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "guidance", "event_label": "Guidance", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "SGHT Forecast \u2014 Price Target \u2014 Prediction for 2027", "summary": "This article provides a forecast for Sight Sciences, Inc. (SGHT) stock, including analyst price targets and predictions for 2027. It details the company's current stock performance, historical highs and lows, volatility, market capitalization, earnings, revenue, and employee coun", "url": "https://www.tradingview.com/symbols/NASDAQ-SGHT/forecast-price-target/", "source_name": "TradingView", "published_at": "2026-06-26T03:40:00", "published_display": "26 Jun 2026 03:40", "sentiment": "positive", "sentiment_pct": 61, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Medical Devices & Supplies - Cardiology, Neurology, Vascular Stocks Q1 Earnings: ICU Medical (NASDAQ:ICUI) Firing on All Cylinders", "summary": "", "url": "https://news.google.com/rss/articles/CBMikAJBVV95cUxQLWl0NWl5MFJhUXFSN0pzSW1sVzJVb21XVml0X0doQnd5eDVUQmVqeFZWSmNmdlZaV2pfbFk3UEl3RXlqZ05pckozR0dnNHNEUlpTa2FPYWc1Z3Q0Y2tXYTljZUlQRkVZNzY2Sl9yRksyUDJkNVQzSTBuLW9uMnI5bzBfTTJGdDUzd25DN3dDSmhwWnpGVXZRVVM2Uy1zMnp4STZ1RGdZZkRpZ21Pb2xtWjRSTk1kc2JrT28wTG81NDV1M2tWaVdrOXBQdVZSTExiTVEzMXpqRnJWWi0xcEdMYVFILXZXbXZVZl9GRm12aTl5OGk4X1dSVjVyU2FIVFpubk1YNm5fQll0MVZqRTZpTA?oc=5", "source_name": "StockStory", "published_at": "2026-06-15T07:00:00+00:00", "published_display": "15 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Q1 Earnings Review: Medical Devices & Supplies - Diversified Stocks Led by Baxter (NYSE:BAX)", "summary": "", "url": "https://news.google.com/rss/articles/CBMipgFBVV95cUxNYjhBT3BjMWFVU1FFUUFub0d6QUVEUTdwWFVMRG5fN2dHSnIxTXQwMWU1aElKaEV1a2dYLTFHMlBzMVFTZEtaX0xRRDFhZDl1WFdDYWF2RDZxOG9SRUtycmZacTRzM2FaaEU3OS1GZ2taLWtSMjZ4enhVNHRvdzJsanp4cEhNcGI1dllTOUplWUUtNjRlRm85MlFEVWxSYUV2d243QVd3?oc=5", "source_name": "Market source", "published_at": "2026-05-21T07:00:00+00:00", "published_display": "21 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Sight Sciences (SGHT) Q1 Loss Of US$0.24 EPS Tests Margin Improvement Narrative", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-05-08T07:00:00+00:00", "published_display": "08 May 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Sight Sciences Q1 Earnings Call Highlights", "summary": "", "url": "https://finance.yahoo.com/m/12d4bd59-6dc8-32e9-b77d-98895ab273a9/sight-sciences-q1-earnings.html", "source_name": "MarketBeat", "published_at": "2026-05-07T05:12:06+00:00", "published_display": "07 May 2026 05:12", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Sight Sciences, Inc. Q1 2026 Earnings Call Summary", "summary": "", "url": "https://finance.yahoo.com/m/e1ca4b12-3685-3bd1-8b52-8340f4bbe021/sight-sciences%2C-inc.-q1-2026.html", "source_name": "Moby", "published_at": "2026-05-07T00:35:25+00:00", "published_display": "07 May 2026 00:35", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Sight Sciences, Inc. (SGHT) Reports Q1 Loss, Beats Revenue Estimates", "summary": "", "url": "https://finance.yahoo.com/markets/stocks/articles/sight-sciences-inc-sght-reports-223007729.html", "source_name": "Zacks", "published_at": "2026-05-06T22:30:07+00:00", "published_display": "06 May 2026 22:30", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Sight Sciences (SGHT) Q1 2026 Earnings Transcript", "summary": "", "url": "https://finance.yahoo.com/m/62478c4a-2a5c-3c08-bd80-1de6bdf80c31/sight-sciences-%28sght%29-q1-2026.html", "source_name": "Motley Fool", "published_at": "2026-05-06T22:25:58+00:00", "published_display": "06 May 2026 22:25", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Sight Sciences Reports First Quarter 2026 Financial Results and Raises Full Year 2026 Revenue Guidance", "summary": "", "url": "https://news.google.com/rss/articles/CBMiggJBVV95cUxQQnNHX2xrVERXN1A4WlBsWkxQU1FYMUZQaFdZRlZUMkFnak11VF9vYTBBTTBhSnBQR3Z2Wnp1N29fZFhfaFNKRGh3T2lxdmpkUXVkNW1yMGE4amlZNUhrSlp4MkllZHZ4c2xzdzQzSldEb0cyQkpRU09HRWdaa3RMQWVQOUxwNFp1b05NUUgwWS1xdUxucEFFLTFMMG9oa2thR2ttNVFNT3JjVFEwTmFuOVBSMjZTelRzMmJjeGh5TTRZRkpfdFNsLWl3UWdJSjNCX2lreE1wY3BJQWF4VTZtVU1OOE9QNG9NVDBSc0JVOWt5WXpoeFRqY0Fkd3d1N2tXQ3c?oc=5", "source_name": "GlobeNewswire", "published_at": "2026-05-06T07:00:00+00:00", "published_display": "06 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Sight Sciences (SGHT) Q1 Earnings: How Key Metrics Compare to Wall Street Estimates", "summary": "", "url": "https://news.google.com/rss/articles/CBMinAFBVV95cUxNaGhScXVwUFoxZHlQWXB2bGtWLWJmSXJxajIzdXdCa3ZEMkY0T1dzS2hWZlFtR19LRG8xTHJhdFlxNE5zaUhUa09FTFRQdDRXN2k0alNzaHVHa3ZaUjlUdk1HdndCOXlLV3VweDFnenF5QkhQUGlxVEhHNlk4Z0pobTg1S2JKQi03cW15dzRMbUt2U3EybTRwb0UwZWw?oc=5", "source_name": "Market source", "published_at": "2026-05-06T07:00:00+00:00", "published_display": "06 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Sight Sciences to Present at Two Upcoming Investor Conferences", "summary": "", "url": "https://news.google.com/rss/articles/CBMijAFBVV95cUxOMDRaakE1c3Z6SHFRWHNQcmNGeFJ6cDMyYTVvbkZsRDhXNVBMUE5jYThlWHJWMFplV2FLcnkwVGJkbFJ6azMxbnRQWGF4SW04eDZWSnNIcm1JNWtqaWRjeWszWXdyWVpqa0hTODJMZFVOd0VOVnVMVmVyTVVmTElmQkZHdFgzeDlOcURPeg?oc=5", "source_name": "Yahoo! Finance Canada", "published_at": "2026-04-29T07:00:00+00:00", "published_display": "29 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Medical Devices & Supplies - Specialty Q4 Earnings: Globus Medical (NYSE:GMED) is the Best in the Biz", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxNcDFMNmtOVk5PVFM1YzMyVWhyS3dwY0dMVE5BUng5U1JoOFRQMXNFRGxTMmlBRUV0bENRSWFXTDFZOXBQQkNZT0FOWDdISjRCcU9pRV9aNHBwUVBuZkVEV3g1dklVY19KOE9iWUNpNUtMS2NuOEcxMlQtNU8ydURybEdkNVoxZThWLTBIeVhid2NjQ0FWWTUzb2dxcmlMQThFQmZ4bldzRjcwUQ?oc=5", "source_name": "Market source", "published_at": "2026-04-27T07:00:00+00:00", "published_display": "27 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Sight Sciences Announces the Release of its Sustainability Report", "summary": "", "url": "https://finance.yahoo.com/sectors/healthcare/articles/sight-sciences-announces-release-sustainability-204500360.html", "source_name": "GlobeNewswire", "published_at": "2026-04-22T20:45:00+00:00", "published_display": "22 Apr 2026 20:45", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Sight Sciences says it donated to 24 programs supporting indigent care", "summary": "", "url": "https://news.google.com/rss/articles/CBMiswFBVV95cUxNdkQtZUZ6Z2tZMWdzSXhOX21sT21mVjNia2NrbGNXc3JZNTR5UlltZlhnVnhZRnMyZ0tpNU54NXNoWkhnWnl0enotX3hXczdvSWpJam9xNjJXUTktVjhOSjBwQmRKS2VsLXRvTGxVaGRHV1NXR25sclU4SW0tSDlUQ21uMEloa1FSZDdoVXNEVXB3bVdhWlpISk9RRElkZmtVNHVVMkZvWnhGeGJMX09CbmREUQ?oc=5", "source_name": "Stock Titan", "published_at": "2026-04-22T07:00:00+00:00", "published_display": "22 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "A Look Back at Medical Devices & Supplies - Imaging, Diagnostics Stocks\u2019 Q4 Earnings: Hologic (NASDAQ:HOLX) Vs The Rest Of The Pack", "summary": "", "url": "https://news.google.com/rss/articles/CBMipgFBVV95cUxOdkl6Ym5HSGVhZUw3TzNlNVFPSjdDQk5NMTVSRW1xVnh3RE5RNU9veVR0TDEtcVdxV3BYelI0bWxCYXgwWmhZQ3ZONUVRdlhjX0ZiMklRVDJQRXN0LXcyVWVnb0E2WTdiRERtZk1pNGpmVHhWbHl5eHJuNnBtTDVPMUluTmRsQUVqYjNlSl8zR3djclh0X2ZIc1gzTlhPanR6ZTJ6R1FB?oc=5", "source_name": "Market source", "published_at": "2026-04-07T07:00:00+00:00", "published_display": "07 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Q4 Earnings Highlights: Artivion (NYSE:AORT) Vs The Rest Of The Medical Devices & Supplies - Cardiology, Neurology, Vascular Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqAFBVV95cUxPaTgxS3dlMlZ5dDZ3dFlGdG9yRWFubkVqMk9yOTN6OEtyemljTWJGYUcxb2pmd2FTNTFKMlhIVGxrdlJsOG5iY1VQaXE4ZmYycTVpRkE0aEJ3QlB5bC10ZXN2dTFYNy0wRWdrNURVUlo5dEMzQklxQ0kwQTRkOXE0UDdTMkRGRWxoQ1ZQeG4tOXNONlR2SkxfZW5ST1B6N3BBeFZZQ3N1UFE?oc=5", "source_name": "Market source", "published_at": "2026-04-02T07:00:00+00:00", "published_display": "02 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Q4 Earnings Highlights: CooperCompanies (NASDAQ:COO) Vs The Rest Of The Medical Devices & Supplies - Diversified Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMitAFBVV95cUxOellVLTAtRXF1dTFacmVLUmptUVpDSkxGX0MtY2hCY2l3ajU4M25SMG95OHdlc1RHN1dmaHZZMF9uQ0o3R1FBa0NzQUtZMjIzMjU1bmttbGZsZUplQkd5Vmd2NEJoQ0NnbVhmVXppdWhiQkdpcGpQVFJVSHRBXy1pbnFJbXI0R2w3MmlvMEdCY2dGYVE4cWY2MENmeEp1ME9mZEFqSDVtdThTMk9kbUhIdXMtR0k?oc=5", "source_name": "Market source", "published_at": "2026-03-25T07:00:00+00:00", "published_display": "25 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Unpacking Q4 Earnings: Integer Holdings (NYSE:ITGR) In The Context Of Other Medical Devices & Supplies - Specialty Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMihAJBVV95cUxNdFRrRlJvM3J3cGJnVEJ6ZndqMnQxWkE4Wm8zTGtPTVc0OTlLN1pwNXIyclNJMFZkcG5qQTRTWThmNm9WN0hKYXBja3N3Y20zSlkxc2JaQlpYTnAyWnpvUVBvR1JWNmVxZGhSYVlYQklMd01GeFBVNGJWOFBWYUkwYmRrM2xrSktiQWpfTkZtNG1HWThNT0tqLUpYek5qcnFWMGE0QV9CaElrMUpfTEhnOC1pS2t1bkE2VVJHdEhWdEtoX2xKNE1MWk1OSlBSNTVZVU83WEpnb3E4aURwQ3ZyZUFDbndpTTZEa0lZRTJvU2VuTDhreXdCQ25iV3Y4YWxENm1xYQ?oc=5", "source_name": "StockStory", "published_at": "2026-03-16T07:00:00+00:00", "published_display": "16 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Q4 Earnings Highs And Lows: Abbott Laboratories (NYSE:ABT) Vs The Rest Of The Medical Devices & Supplies - Diversified Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMigAFBVV95cUxPeVpVN2I3X3lJNXd3TXJmRWV4X0RvRDdYR3l5a1k1SjMxUlhsWHdrUUNuZ1JIaUg4czdhZlA2VDVIallROFFuNmZXcnNzS1d3Vm0wS0tLMmlFVWdkUThsRDZYdTdZV3k3WkRjaUZSMUQ3dkRKYm5ZOVBjMVVBdTRjYQ?oc=5", "source_name": "Market source", "published_at": "2026-03-12T07:00:00+00:00", "published_display": "12 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Unpacking Q4 Earnings: Enovis (NYSE:ENOV) In The Context Of Other Medical Devices & Supplies - Specialty Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMihgFBVV95cUxNMzBPcXU1cnZKekZnaGlNVk05ZWFTWThNOS0tTlpvQjdaLVZIWlVXUk50NnVoQ0pPWWJpZUpWcVJyVDJMd2RJREVDbEEzTlU5UGhBbWtxWVEyVkdaMTVuNXZpaWFMNTZUQ2d0OW9Rc29kalJRY21naWlHZDBLS3RuZV9wdTdIUQ?oc=5", "source_name": "Market source", "published_at": "2026-03-10T07:00:00+00:00", "published_display": "10 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Sight Sciences Inc. (SGHT) Stock Falls on Q4 2025 Earnings", "summary": "", "url": "https://news.google.com/rss/articles/CBMimwFBVV95cUxOcXhUM3Vldkc5YTZGRkYzaDRWdmY4ZXR5RVVIODZoWGJpTng5a0o4N3lfa0k4eUQzU3RLWXVSUFVMQnEwYVFxMmhpbVVTTWpLR1ZQYUdyLWFpTS1DUGRzdzlxM2h3NlduYnctc195b29jQWZGQktfMVIwMG9KYThSbVdrOGtzTkRRYVJPYmR0MWpMTGJSa0dIYlJtRQ?oc=5", "source_name": "Quiver Quantitative", "published_at": "2026-03-04T08:00:00+00:00", "published_display": "04 Mar 2026 08:00", "sentiment": "negative", "sentiment_pct": 22, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Q4 Earnings Highs And Lows: Baxter (NYSE:BAX) Vs The Rest Of The Medical Devices & Supplies - Diversified Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMigAFBVV95cUxOb3BiQVNFREdNblk2QS10b1lhRUtfb05vU2VFZHB5V0hJT0R4NmhwQWRrcFVsR3UwMjZleFV6N2FEelpZVzY3YWFxSWE1cWpLaTFrQVU4NktkQUloUkxaV3ZTVkh6b1ZmaDdMN2ViX1BUNE4xUTNUZFNlR0syVGlZSg?oc=5", "source_name": "Market source", "published_at": "2026-03-02T08:00:00+00:00", "published_display": "02 Mar 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "This Insider Has Just Sold Shares In Sight Sciences", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-01-08T08:00:00+00:00", "published_display": "08 Jan 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Sight Sciences Announces Medicare Pricing for TearCare\u00ae Procedure in Novitas and First Coast Jurisdictions", "summary": "", "url": "https://news.google.com/rss/articles/CBMi3AFBVV95cUxQLWhZb1dRcEZ2WnRZal9PeWZKTkZXWWxzdEpxOUVpV3JJaXdMX21tQ1U1bmdTeVpWSjltNmxoVmxVTDhxTzNsZ2JnVVZyb1pQZlJ2aG11YWFhTTJJOURYdWh6WVd2RTBTOUdabmxIUVhOcFAwcm15b3hxZ05PXzVwMDRzRjY2T09kc3dfeHFXTUZQSmxhMXdoS2NTQy10V2Z4VkI1MzZYWkh1SG5SaGZXdXlCSkhiaHBDSTlNVWY3azROTW9zUDF5RnFBUnFkU3p6SlFTMkg3aVc1QThR?oc=5", "source_name": "Quiver Quantitative", "published_at": "2025-10-17T07:00:00+00:00", "published_display": "17 Oct 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "by_tier": {"direct": [{"title": "Have Insiders Sold Sight Sciences Shares Recently?", "summary": "Sight Sciences Co-Founder Paul Badawi recently sold US$155k worth of shares at US$5.42, which was 0.5% of his holding. While this sale, and a previous larger one at a higher price, indicates more insider selling than buying over the last year, the stock was sold above the current", "url": "https://simplywall.st/stocks/us/healthcare/nasdaq-sght/sight-sciences/news/have-insiders-sold-sight-sciences-shares-recently", "source_name": "Simply Wall Street", "published_at": "2026-07-09T10:49:02", "published_display": "09 Jul 2026 10:49", "sentiment": "negative", "sentiment_pct": 40, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Citi Maintains Sight Sciences(SGHT.US) With Hold Rating, Raises Target Price to $6", "summary": "Citi has reiterated its Hold rating for Sight Sciences (SGHT.US), increasing the target price for the company's stock to $6. This updated target indicates Citi's revised valuation for the medical device company.", "url": "https://www.moomoo.com/news/post/72646288/citi-maintains-sight-sciences-sghtus-with-hold-rating-raises-target", "source_name": "Moomoo", "published_at": "2026-07-08T21:12:39", "published_display": "08 Jul 2026 21:12", "sentiment": "positive", "sentiment_pct": 70, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Sight Sciences Inc focuses on glaucoma devices as investors watch Nasdaq trading", "summary": "Sight Sciences Inc is a US-based medical technology company specializing in devices for glaucoma and dry eye treatment, with its shares listed on Nasdaq. The company\u2019s strategy focuses on developing minimally invasive solutions to address chronic eye conditions in a growing ophth", "url": "https://www.ad-hoc-news.de/boerse/news/ueberblick/sight-sciences-inc-focuses-on-glaucoma-devices-as-investors-watch-nasdaq/69726297", "source_name": "AD HOC NEWS", "published_at": "2026-07-08T18:40:18", "published_display": "08 Jul 2026 18:40", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Form 4 Sight Sciences Inc For: 6 July By Investing.com", "summary": "This article from Investing.com announces the filing of Form 4 for Sight Sciences Inc. on July 6. It also includes general market data, news headlines, and various financial statistics as supplementary content. The core purpose of the article is to report on the Form 4 filing.", "url": "https://uk.investing.com/news/stock-market-news/form-4-sight-sciences-inc-for-6-july-93CH-4758634", "source_name": "Investing.com UK", "published_at": "2026-07-07T23:11:14", "published_display": "07 Jul 2026 23:11", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Sight Sciences (NASDAQ: SGHT) CFO sells 6,902 shares to cover RSU tax bill", "summary": "Sight Sciences CFO James Rodberg sold 6,902 shares of common stock on July 2, 2026, at a weighted average price of $5.36 per share. The sale was conducted to cover tax obligations related to the vesting of his restricted stock units (RSUs). Following this transaction, Rodberg ret", "url": "https://www.stocktitan.net/sec-filings/SGHT/form-4-sight-sciences-inc-insider-trading-activity-b49fe6614591.html", "source_name": "Stock Titan", "published_at": "2026-07-07T20:49:03", "published_display": "07 Jul 2026 20:49", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Sight Sciences CLO Jeremy Hayden sells $70,133 in stock", "summary": "Jeremy Hayden, CLO at Sight Sciences (NASDAQ:SGHT), sold 12,733 shares for $70,133 to cover tax liabilities associated with restricted stock units. Despite this insider sale, Hayden still directly holds 357,037 shares. Investing.com analysis suggests the stock is currently overva", "url": "https://www.investing.com/news/insider-trading-news/sight-sciences-clo-jeremy-hayden-sells-70133-in-stock-93CH-4778033", "source_name": "Investing.com", "published_at": "2026-07-07T20:49:03", "published_display": "07 Jul 2026 20:49", "sentiment": "negative", "sentiment_pct": 37, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Form 144 Sight Sciences For: 6 July By Investing.com", "summary": "This article from Investing.com briefly notes the filing of Form 144 for Sight Sciences (SGHT) on July 6. The content is primarily a placeholder for this financial reporting and includes various market data, news headlines, and related financial information, but no further detail", "url": "https://ng.investing.com/news/stock-market-news/form-144-sight-sciences-for-6-july-93CH-2587958", "source_name": "Investing.com Nigeria", "published_at": "2026-07-07T20:40:18", "published_display": "07 Jul 2026 20:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price to earnings forward of Sight Sciences, Inc. \u2013 NASDAQ:SGHT", "summary": "This article provides financial information for Sight Sciences, Inc. (NASDAQ: SGHT), specifically focusing on its price-to-earnings forward ratio. The content appears to be a stub or an incomplete data point from a financial platform like TradingView, as it lacks detailed analyti", "url": "https://www.tradingview.com/symbols/NASDAQ-SGHT/financials-statistics-and-ratios/price-earnings-fwd/", "source_name": "TradingView", "published_at": "2026-07-07T10:12:53", "published_display": "07 Jul 2026 10:12", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Sight Sciences CFO James Rodberg sells $36,994 in common shares", "summary": "Sight Sciences CFO James Rodberg sold 6,902 common shares worth $36,994 to cover tax liabilities from vesting stock units. Following the transaction, Rodberg directly holds 224,037 shares. The company recently reported mixed Q1 2026 earnings, exceeding revenue expectations but mi", "url": "https://www.investing.com/news/insider-trading-news/sight-sciences-cfo-james-rodberg-sells-36994-in-common-shares-93CH-4778032", "source_name": "Investing.com", "published_at": "2026-07-07T09:40:20", "published_display": "07 Jul 2026 09:40", "sentiment": "negative", "sentiment_pct": 39, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Sight Sciences (SGHT) EVP sells shares to cover RSU-related tax obligations", "summary": "Taylor Brenton, EVP of Operations & R&D at Sight Sciences (SGHT), sold 2,829 shares of company stock at a weighted average price of $5.42 per share. This sale, totaling $15,333, was primarily to cover tax obligations arising from the vesting of restricted stock units (RSUs) rathe", "url": "https://www.stocktitan.net/sec-filings/SGHT/form-4-sight-sciences-inc-insider-trading-activity-0de92e5ce41b.html", "source_name": "Stock Titan", "published_at": "2026-07-07T08:11:15", "published_display": "07 Jul 2026 08:11", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Sight Sciences CFO James Rodberg sells $36,994 in common shares By Investing.com", "summary": "", "url": "https://news.google.com/rss/articles/CBMivwFBVV95cUxPTnM4YVdXSk81Q3IxZUY2TWtZZHpJazhXRkw3S1RFYlEyTjc4bkRhdHpZN1MtT0RCY0Z5R0V6dklCLWNkVzJ1NGowVXlsenpaVUZnZHZpdEt6YWdJXzhuWFNoaTdNSE9JcUFHS3VoUXotN0JTcU0tYWhPOWNWSGdobVJhRWRFZ2V4SS1DU0E0MFRrQ2Y0UEc4UUdhaFh5MW5JMjJKemVKT0RMamF4c3dRZm45aWhtUEFNN2d6TE14Zw?oc=5", "source_name": "Investing.com Nigeria", "published_at": "2026-07-07T00:04:22+00:00", "published_display": "07 Jul 2026 00:04", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Sight Sciences COO Alison Bauerlein sells $129,626 in stock By Investing.com", "summary": "Sight Sciences COO Alison Bauerlein sold 24,184 shares of company stock worth $129,626 to cover tax liabilities. Following the sale, she directly holds 664,709 shares. This transaction comes amidst mixed Q1 2026 earnings for Sight Sciences, where revenue beat expectations but EPS", "url": "https://m.za.investing.com/news/stock-market-news/sight-sciences-coo-alison-bauerlein-sells-129626-in-stock-93CH-4357436?ampMode=1", "source_name": "Investing.com South Africa", "published_at": "2026-07-07T00:11:14", "published_display": "07 Jul 2026 00:11", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 93, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Sight Sciences CLO Jeremy Hayden sells $70,133 in stock By Investing.com", "summary": "Jeremy B. Hayden, Chief Legal Officer at Sight Sciences, Inc. (NASDAQ:SGHT), sold 12,733 shares of company stock for $70,133 to cover tax liabilities. Following the sale, he still directly holds 357,037 shares, including unvested restricted stock units. This transaction comes aft", "url": "https://m.za.investing.com/news/stock-market-news/sight-sciences-clo-jeremy-hayden-sells-70133-in-stock-93CH-4357444?ampMode=1", "source_name": "Investing.com South Africa", "published_at": "2026-07-07T00:11:14", "published_display": "07 Jul 2026 00:11", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Sight Sciences (SGHT) COO sells shares to cover RSU tax, retains 664,709 stake", "summary": "Sight Sciences, Inc. COO Alison Bauerlein sold 24,184 shares of common stock at a weighted average price of $5.36 per share. This sale was conducted to cover tax liabilities stemming from the vesting of restricted stock units (RSUs). Following this transaction, Bauerlein still ho", "url": "https://www.stocktitan.net/sec-filings/SGHT/form-4-sight-sciences-inc-insider-trading-activity-3120a5661f2c.html", "source_name": "Stock Titan", "published_at": "2026-07-06T23:11:15", "published_display": "06 Jul 2026 23:11", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Sight Sciences CEO Paul Badawi disposes of $155,467 in stock By Investing.com", "summary": "Paul Badawi, President and CEO of Sight Sciences Inc. (NASDAQ:SGHT), sold 28,684 shares of the company's common stock for $155,467 on July 1, 2026, to cover tax liabilities related to restricted stock units. Following this transaction, Badawi directly holds over 6.1 million share", "url": "https://m.za.investing.com/news/stock-market-news/sight-sciences-ceo-paul-badawi-disposes-of-155467-in-stock-93CH-4357438?ampMode=1", "source_name": "Investing.com South Africa", "published_at": "2026-07-06T23:11:15", "published_display": "06 Jul 2026 23:11", "sentiment": "negative", "sentiment_pct": 39, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Sight Sciences (NASDAQ: SGHT) CLO sells 12,733 shares to cover RSU taxes", "summary": "Sight Sciences Chief Legal Officer Jeremy B. Hayden sold 12,733 shares of common stock at a weighted average price of $5.51 per share. This sale was explicitly made to cover tax liabilities arising from the vesting of restricted stock units (RSUs), rather than a discretionary red", "url": "https://www.stocktitan.net/sec-filings/SGHT/form-4-sight-sciences-inc-insider-trading-activity-f048f8d1103f.html", "source_name": "Stock Titan", "published_at": "2026-07-06T23:11:14", "published_display": "06 Jul 2026 23:11", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Sight Sciences (SGHT) CTO sells 7,418 shares to cover RSU tax liability", "summary": "Sight Sciences, Inc. Chief Technology Officer David Badawi sold 7,418 shares of common stock at a weighted average price of $5.508 per share to cover tax liabilities from restricted stock unit vesting. Following this transaction, Badawi still holds 1,982,872 shares, comprising co", "url": "https://www.stocktitan.net/sec-filings/SGHT/form-4-sight-sciences-inc-insider-trading-activity-4982eb9526cc.html", "source_name": "Stock Titan", "published_at": "2026-07-06T23:11:14", "published_display": "06 Jul 2026 23:11", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Sight Sciences (SGHT) CEO\u2019s 28,684-share tax sale and updated holdings", "summary": "Sight Sciences, Inc. President and CEO Paul Badawi sold 28,684 shares of common stock at a weighted average price of $5.42 per share. This sale was conducted to cover his tax liability arising from the vesting of restricted stock units (RSUs). After this transaction, Badawi still", "url": "https://www.stocktitan.net/sec-filings/SGHT/form-4-sight-sciences-inc-insider-trading-activity-4c44b164d00b.html", "source_name": "Stock Titan", "published_at": "2026-07-06T23:11:14", "published_display": "06 Jul 2026 23:11", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "[144] Sight Sciences, Inc. SEC Filing", "summary": "This article details a Form 144 SEC filing by Sight Sciences, Inc. (SGHT) concerning a proposed sale of securities. The filing indicates the sale of 7,418 common shares acquired via restricted stock vesting on June 30, 2026, with an approximate sale date of July 6, 2026, through ", "url": "https://www.stocktitan.net/sec-filings/SGHT/144-sight-sciences-inc-sec-filing-017eb01cabc7.html", "source_name": "Stock Titan", "published_at": "2026-07-06T21:12:53", "published_display": "06 Jul 2026 21:12", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Sight Sciences COO Alison Bauerlein sells $129,626 in stock", "summary": "Alison Bauerlein, COO of Sight Sciences, Inc. (NASDAQ:SGHT), sold 24,184 shares of company stock for approximately $129,626 to cover tax liabilities from vested restricted stock units. Following the sale, she directly holds 664,709 shares, including unvested RSUs. The company rec", "url": "https://www.investing.com/news/insider-trading-news/sight-sciences-coo-alison-bauerlein-sells-129626-in-stock-93CH-4778026", "source_name": "Investing.com", "published_at": "2026-07-06T09:40:20", "published_display": "06 Jul 2026 09:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Sight Sciences EVP Brenton Taylor sells $15,333 in company stock", "summary": "", "url": "https://news.google.com/rss/articles/CBMixgFBVV95cUxQREw1a3ptd2dmVXk4TS1XdE9vdngyT2FSbHZXaHlCMTNValZDaWRMcnk1TUVWTS1Uamt6Y3RrOGstNE5EekJzX1JiWkE2RDRpSGdJeENlOE1PZC1SdjlYWGhXb2xHSG5QWllvZlZoQWdNQTV0eFpNeXhVTW40NnBfYnN2ZHRNaHNNNUREUkQza0NPQjhBbE9wU2x4STJRaEd3aV9hMkxOaDRmTE13Yy02Mk5OSTZ5OVNWOUNoakkyVEFnOGZGU2c?oc=5", "source_name": "Investing.com", "published_at": "2026-07-06T07:00:00+00:00", "published_display": "06 Jul 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "SGHT (NASDAQ: SGHT) affiliate files Form 144 to sell 12,733 shares", "summary": "", "url": "https://news.google.com/rss/articles/CBMimwFBVV95cUxQcWpuLS0xbGR1d29hdEhFSGU1azdKSS0ybEdGUFdoNDZLYkJadkRLclFTVG9Wb1UwNENGazcza1NwMzhfVEgtczdaWFB4ZDlQLWZ4R1V4R0VaUTdSVzZNTzJHV0V6RDJvcHZpT21NV0ZWUWw3d2ZhVVk2TmtSNUMyWVotc2gzcUFJbFNXbEIxdzJZSml2ZTNFN2taRQ?oc=5", "source_name": "Stock Titan", "published_at": "2026-07-06T07:00:00+00:00", "published_display": "06 Jul 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Sight Sciences CTO David Badawi sells $40,858 in stock", "summary": "Sight Sciences CTO David Badawi sold 7,418 shares of the company's common stock for $40,858 to cover tax liabilities from restricted stock units. Following the sale, Badawi still holds a significant number of shares, including vested and unvested RSUs. InvestingPro analysis sugge", "url": "https://www.investing.com/news/insider-trading-news/sight-sciences-cto-david-badawi-sells-40858-in-stock-93CH-4778036", "source_name": "Investing.com", "published_at": "2026-07-06T07:39:00", "published_display": "06 Jul 2026 07:39", "sentiment": "negative", "sentiment_pct": 39, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price to book forward of Sight Sciences, Inc. \u2013 NASDAQ:SGHT", "summary": "This article displays the \"Price to book forward\" financial metric for Sight Sciences, Inc. (NASDAQ: SGHT). It presents the current value, change, and percentage change for this specific financial statistic. The content is presented by TradingView, sourcing data from ICE Data Ser", "url": "https://www.tradingview.com/symbols/NASDAQ-SGHT/financials-statistics-and-ratios/price-book-fwd/", "source_name": "TradingView", "published_at": "2026-07-05T13:40:49", "published_display": "05 Jul 2026 13:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Form 144 Sight Sciences For: 2 July By Investing.com", "summary": "This article announces the filing of Form 144 for Sight Sciences (SGHT) on July 2. Form 144 filings indicate an insider's intent to sell restricted stock. The brief piece reiterates the headline multiple times and includes a market data table.", "url": "https://ca.investing.com/news/stock-market-news/form-144-sight-sciences-for-2-july-93CH-4719350", "source_name": "Investing.com Canada", "published_at": "2026-07-02T22:39:18", "published_display": "02 Jul 2026 22:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "SGHT (NASDAQ) Form 144 shows 6,902-share resale after restricted-vesting", "summary": "Sight Sciences, Inc. (SGHT) filed a Form 144 notification indicating a proposed sale of 6,902 shares of common stock stemming from restricted stock vesting. The filing also disclosed 54,409,942 shares outstanding as of July 2, 2026, and reported a prior sale of 7,231 shares on Ap", "url": "https://www.stocktitan.net/sec-filings/SGHT/144-sight-sciences-inc-sec-filing-1c1b9a4cee3b.html", "source_name": "Stock Titan", "published_at": "2026-07-02T21:39:18", "published_display": "02 Jul 2026 21:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "SGHT (NASDAQ) insider resale notice: 24,184 shares tied to vesting", "summary": "Sight Sciences, Inc. (SGHT) filed a Form 144 notice disclosing the proposed resale of 24,184 shares of common stock associated with a restricted stock vesting event on June 30, 2026. The filing also detailed two prior open-market sales by an insider on April 2, 2026, and May 18, ", "url": "https://www.stocktitan.net/sec-filings/SGHT/144-sight-sciences-inc-sec-filing-3ed6c731940d.html", "source_name": "Stock Titan", "published_at": "2026-07-02T21:39:17", "published_display": "02 Jul 2026 21:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "2,829 Restricted Shares for SGHT (NASDAQ: SGHT) - Form 144 Notice", "summary": "A Form 144 notice has been filed for Sight Sciences, Inc. (NASDAQ: SGHT), indicating an intent to sell 2,829 shares of common stock stemming from restricted stock vesting. The event date for the vesting is June 30, 2026, with Fidelity Brokerage Services LLC listed as the broker. ", "url": "https://www.stocktitan.net/sec-filings/SGHT/144-sight-sciences-inc-sec-filing-c35be394a5d0.html", "source_name": "Stock Titan", "published_at": "2026-07-01T21:09:24", "published_display": "01 Jul 2026 21:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "SGHT (NASDAQ: SGHT) files notice for 28,684\u2011share restricted stock sale", "summary": "Sight Sciences, Inc. (NASDAQ: SGHT) has filed a Form 144 notice for the proposed sale of 28,684 shares of common stock resulting from restricted stock vesting on June 30, 2026. The filing also disclosed a previous sale by Paul Badawi of 29,244 shares on April 1, 2026, for $108,08", "url": "https://www.stocktitan.net/sec-filings/SGHT/144-sight-sciences-inc-sec-filing-6dd29bcc9626.html", "source_name": "Stock Titan", "published_at": "2026-07-01T21:09:24", "published_display": "01 Jul 2026 21:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Form 144 Sight Sciences For: 1 July By Investing.com", "summary": "This article from Investing.com reports on a Form 144 filing for Sight Sciences (SGHT) on July 1st. The brief piece indicates that SGHT's stock is up 0.37% and encourages readers to view comments, though none are present. It serves as a concise notification of the regulatory fili", "url": "https://ca.investing.com/news/stock-market-news/form-144-sight-sciences-for-1-july-93CH-4717094", "source_name": "Investing.com Canada", "published_at": "2026-07-01T21:09:24", "published_display": "01 Jul 2026 21:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Sight Sciences, Inc. Actuals & Estimates (NASDAQ:SGHT)", "summary": "Sight Sciences, Inc. (NASDAQ: SGHT) stock has seen significant increases recently, rising 4.21% in the past 24 hours, 11.13% over the last week, and 13.12% in the last month. Analysts have a wide forecast range for SGHT, with a max estimate of $12.00 and a min of $5.15. The compa", "url": "https://www.tradingview.com/symbols/NASDAQ-SGHT/forecast-actuals-and-estimates/", "source_name": "TradingView", "published_at": "2026-06-26T15:40:29", "published_display": "26 Jun 2026 15:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "guidance", "event_label": "Guidance", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "SGHT Forecast \u2014 Price Target \u2014 Prediction for 2027", "summary": "This article provides a forecast for Sight Sciences, Inc. (SGHT) stock, including analyst price targets and predictions for 2027. It details the company's current stock performance, historical highs and lows, volatility, market capitalization, earnings, revenue, and employee coun", "url": "https://www.tradingview.com/symbols/NASDAQ-SGHT/forecast-price-target/", "source_name": "TradingView", "published_at": "2026-06-26T03:40:00", "published_display": "26 Jun 2026 03:40", "sentiment": "positive", "sentiment_pct": 61, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Sight Sciences (SGHT) Q1 Loss Of US$0.24 EPS Tests Margin Improvement Narrative", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-05-08T07:00:00+00:00", "published_display": "08 May 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Sight Sciences Q1 Earnings Call Highlights", "summary": "", "url": "https://finance.yahoo.com/m/12d4bd59-6dc8-32e9-b77d-98895ab273a9/sight-sciences-q1-earnings.html", "source_name": "MarketBeat", "published_at": "2026-05-07T05:12:06+00:00", "published_display": "07 May 2026 05:12", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Sight Sciences, Inc. Q1 2026 Earnings Call Summary", "summary": "", "url": "https://finance.yahoo.com/m/e1ca4b12-3685-3bd1-8b52-8340f4bbe021/sight-sciences%2C-inc.-q1-2026.html", "source_name": "Moby", "published_at": "2026-05-07T00:35:25+00:00", "published_display": "07 May 2026 00:35", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Sight Sciences, Inc. (SGHT) Reports Q1 Loss, Beats Revenue Estimates", "summary": "", "url": "https://finance.yahoo.com/markets/stocks/articles/sight-sciences-inc-sght-reports-223007729.html", "source_name": "Zacks", "published_at": "2026-05-06T22:30:07+00:00", "published_display": "06 May 2026 22:30", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Sight Sciences (SGHT) Q1 2026 Earnings Transcript", "summary": "", "url": "https://finance.yahoo.com/m/62478c4a-2a5c-3c08-bd80-1de6bdf80c31/sight-sciences-%28sght%29-q1-2026.html", "source_name": "Motley Fool", "published_at": "2026-05-06T22:25:58+00:00", "published_display": "06 May 2026 22:25", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Sight Sciences Reports First Quarter 2026 Financial Results and Raises Full Year 2026 Revenue Guidance", "summary": "", "url": "https://news.google.com/rss/articles/CBMiggJBVV95cUxQQnNHX2xrVERXN1A4WlBsWkxQU1FYMUZQaFdZRlZUMkFnak11VF9vYTBBTTBhSnBQR3Z2Wnp1N29fZFhfaFNKRGh3T2lxdmpkUXVkNW1yMGE4amlZNUhrSlp4MkllZHZ4c2xzdzQzSldEb0cyQkpRU09HRWdaa3RMQWVQOUxwNFp1b05NUUgwWS1xdUxucEFFLTFMMG9oa2thR2ttNVFNT3JjVFEwTmFuOVBSMjZTelRzMmJjeGh5TTRZRkpfdFNsLWl3UWdJSjNCX2lreE1wY3BJQWF4VTZtVU1OOE9QNG9NVDBSc0JVOWt5WXpoeFRqY0Fkd3d1N2tXQ3c?oc=5", "source_name": "GlobeNewswire", "published_at": "2026-05-06T07:00:00+00:00", "published_display": "06 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Sight Sciences (SGHT) Q1 Earnings: How Key Metrics Compare to Wall Street Estimates", "summary": "", "url": "https://news.google.com/rss/articles/CBMinAFBVV95cUxNaGhScXVwUFoxZHlQWXB2bGtWLWJmSXJxajIzdXdCa3ZEMkY0T1dzS2hWZlFtR19LRG8xTHJhdFlxNE5zaUhUa09FTFRQdDRXN2k0alNzaHVHa3ZaUjlUdk1HdndCOXlLV3VweDFnenF5QkhQUGlxVEhHNlk4Z0pobTg1S2JKQi03cW15dzRMbUt2U3EybTRwb0UwZWw?oc=5", "source_name": "Market source", "published_at": "2026-05-06T07:00:00+00:00", "published_display": "06 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Sight Sciences to Present at Two Upcoming Investor Conferences", "summary": "", "url": "https://news.google.com/rss/articles/CBMijAFBVV95cUxOMDRaakE1c3Z6SHFRWHNQcmNGeFJ6cDMyYTVvbkZsRDhXNVBMUE5jYThlWHJWMFplV2FLcnkwVGJkbFJ6azMxbnRQWGF4SW04eDZWSnNIcm1JNWtqaWRjeWszWXdyWVpqa0hTODJMZFVOd0VOVnVMVmVyTVVmTElmQkZHdFgzeDlOcURPeg?oc=5", "source_name": "Yahoo! Finance Canada", "published_at": "2026-04-29T07:00:00+00:00", "published_display": "29 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Sight Sciences Announces the Release of its Sustainability Report", "summary": "", "url": "https://finance.yahoo.com/sectors/healthcare/articles/sight-sciences-announces-release-sustainability-204500360.html", "source_name": "GlobeNewswire", "published_at": "2026-04-22T20:45:00+00:00", "published_display": "22 Apr 2026 20:45", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Sight Sciences says it donated to 24 programs supporting indigent care", "summary": "", "url": "https://news.google.com/rss/articles/CBMiswFBVV95cUxNdkQtZUZ6Z2tZMWdzSXhOX21sT21mVjNia2NrbGNXc3JZNTR5UlltZlhnVnhZRnMyZ0tpNU54NXNoWkhnWnl0enotX3hXczdvSWpJam9xNjJXUTktVjhOSjBwQmRKS2VsLXRvTGxVaGRHV1NXR25sclU4SW0tSDlUQ21uMEloa1FSZDdoVXNEVXB3bVdhWlpISk9RRElkZmtVNHVVMkZvWnhGeGJMX09CbmREUQ?oc=5", "source_name": "Stock Titan", "published_at": "2026-04-22T07:00:00+00:00", "published_display": "22 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Sight Sciences Inc. (SGHT) Stock Falls on Q4 2025 Earnings", "summary": "", "url": "https://news.google.com/rss/articles/CBMimwFBVV95cUxOcXhUM3Vldkc5YTZGRkYzaDRWdmY4ZXR5RVVIODZoWGJpTng5a0o4N3lfa0k4eUQzU3RLWXVSUFVMQnEwYVFxMmhpbVVTTWpLR1ZQYUdyLWFpTS1DUGRzdzlxM2h3NlduYnctc195b29jQWZGQktfMVIwMG9KYThSbVdrOGtzTkRRYVJPYmR0MWpMTGJSa0dIYlJtRQ?oc=5", "source_name": "Quiver Quantitative", "published_at": "2026-03-04T08:00:00+00:00", "published_display": "04 Mar 2026 08:00", "sentiment": "negative", "sentiment_pct": 22, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "This Insider Has Just Sold Shares In Sight Sciences", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-01-08T08:00:00+00:00", "published_display": "08 Jan 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Sight Sciences Announces Medicare Pricing for TearCare\u00ae Procedure in Novitas and First Coast Jurisdictions", "summary": "", "url": "https://news.google.com/rss/articles/CBMi3AFBVV95cUxQLWhZb1dRcEZ2WnRZal9PeWZKTkZXWWxzdEpxOUVpV3JJaXdMX21tQ1U1bmdTeVpWSjltNmxoVmxVTDhxTzNsZ2JnVVZyb1pQZlJ2aG11YWFhTTJJOURYdWh6WVd2RTBTOUdabmxIUVhOcFAwcm15b3hxZ05PXzVwMDRzRjY2T09kc3dfeHFXTUZQSmxhMXdoS2NTQy10V2Z4VkI1MzZYWkh1SG5SaGZXdXlCSkhiaHBDSTlNVWY3azROTW9zUDF5RnFBUnFkU3p6SlFTMkg3aVc1QThR?oc=5", "source_name": "Quiver Quantitative", "published_at": "2025-10-17T07:00:00+00:00", "published_display": "17 Oct 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "industry": [{"title": "Reflecting On Medical Devices & Supplies - Specialty Stocks\u2019 Q1 Earnings: Integer Holdings (NYSE:ITGR)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxNUFd1SUpRcWlCdEFjU1YzNTZkdjBfRkwyY2lBYjh1ZXZlZTlyVlpWSWx1bExvckFrNHNhUEdVTGNFWUxaMkVDZUV2c2hPS1h2YVhNSHNsVzFYNUFrNHBnRVM1STRsa2Zmb0VXeEQ4UFRGNDBOWXZfWVU5VFUyQ3JZZm9KamZMWXVDSEtNMWwyVktpaEZfRjVNU1BYaWJ3NnpNUmRyMEpsSzBXdw?oc=5", "source_name": "Market source", "published_at": "2026-07-14T18:07:11+00:00", "published_display": "14 Jul 2026 18:07", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Medical Devices & Supplies - Cardiology, Neurology, Vascular Stocks Q1 Earnings: ICU Medical (NASDAQ:ICUI) Firing on All Cylinders", "summary": "", "url": "https://news.google.com/rss/articles/CBMikAJBVV95cUxQLWl0NWl5MFJhUXFSN0pzSW1sVzJVb21XVml0X0doQnd5eDVUQmVqeFZWSmNmdlZaV2pfbFk3UEl3RXlqZ05pckozR0dnNHNEUlpTa2FPYWc1Z3Q0Y2tXYTljZUlQRkVZNzY2Sl9yRksyUDJkNVQzSTBuLW9uMnI5bzBfTTJGdDUzd25DN3dDSmhwWnpGVXZRVVM2Uy1zMnp4STZ1RGdZZkRpZ21Pb2xtWjRSTk1kc2JrT28wTG81NDV1M2tWaVdrOXBQdVZSTExiTVEzMXpqRnJWWi0xcEdMYVFILXZXbXZVZl9GRm12aTl5OGk4X1dSVjVyU2FIVFpubk1YNm5fQll0MVZqRTZpTA?oc=5", "source_name": "StockStory", "published_at": "2026-06-15T07:00:00+00:00", "published_display": "15 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Q1 Earnings Review: Medical Devices & Supplies - Diversified Stocks Led by Baxter (NYSE:BAX)", "summary": "", "url": "https://news.google.com/rss/articles/CBMipgFBVV95cUxNYjhBT3BjMWFVU1FFUUFub0d6QUVEUTdwWFVMRG5fN2dHSnIxTXQwMWU1aElKaEV1a2dYLTFHMlBzMVFTZEtaX0xRRDFhZDl1WFdDYWF2RDZxOG9SRUtycmZacTRzM2FaaEU3OS1GZ2taLWtSMjZ4enhVNHRvdzJsanp4cEhNcGI1dllTOUplWUUtNjRlRm85MlFEVWxSYUV2d243QVd3?oc=5", "source_name": "Market source", "published_at": "2026-05-21T07:00:00+00:00", "published_display": "21 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Medical Devices & Supplies - Specialty Q4 Earnings: Globus Medical (NYSE:GMED) is the Best in the Biz", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxNcDFMNmtOVk5PVFM1YzMyVWhyS3dwY0dMVE5BUng5U1JoOFRQMXNFRGxTMmlBRUV0bENRSWFXTDFZOXBQQkNZT0FOWDdISjRCcU9pRV9aNHBwUVBuZkVEV3g1dklVY19KOE9iWUNpNUtMS2NuOEcxMlQtNU8ydURybEdkNVoxZThWLTBIeVhid2NjQ0FWWTUzb2dxcmlMQThFQmZ4bldzRjcwUQ?oc=5", "source_name": "Market source", "published_at": "2026-04-27T07:00:00+00:00", "published_display": "27 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "A Look Back at Medical Devices & Supplies - Imaging, Diagnostics Stocks\u2019 Q4 Earnings: Hologic (NASDAQ:HOLX) Vs The Rest Of The Pack", "summary": "", "url": "https://news.google.com/rss/articles/CBMipgFBVV95cUxOdkl6Ym5HSGVhZUw3TzNlNVFPSjdDQk5NMTVSRW1xVnh3RE5RNU9veVR0TDEtcVdxV3BYelI0bWxCYXgwWmhZQ3ZONUVRdlhjX0ZiMklRVDJQRXN0LXcyVWVnb0E2WTdiRERtZk1pNGpmVHhWbHl5eHJuNnBtTDVPMUluTmRsQUVqYjNlSl8zR3djclh0X2ZIc1gzTlhPanR6ZTJ6R1FB?oc=5", "source_name": "Market source", "published_at": "2026-04-07T07:00:00+00:00", "published_display": "07 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Q4 Earnings Highlights: Artivion (NYSE:AORT) Vs The Rest Of The Medical Devices & Supplies - Cardiology, Neurology, Vascular Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqAFBVV95cUxPaTgxS3dlMlZ5dDZ3dFlGdG9yRWFubkVqMk9yOTN6OEtyemljTWJGYUcxb2pmd2FTNTFKMlhIVGxrdlJsOG5iY1VQaXE4ZmYycTVpRkE0aEJ3QlB5bC10ZXN2dTFYNy0wRWdrNURVUlo5dEMzQklxQ0kwQTRkOXE0UDdTMkRGRWxoQ1ZQeG4tOXNONlR2SkxfZW5ST1B6N3BBeFZZQ3N1UFE?oc=5", "source_name": "Market source", "published_at": "2026-04-02T07:00:00+00:00", "published_display": "02 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Q4 Earnings Highlights: CooperCompanies (NASDAQ:COO) Vs The Rest Of The Medical Devices & Supplies - Diversified Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMitAFBVV95cUxOellVLTAtRXF1dTFacmVLUmptUVpDSkxGX0MtY2hCY2l3ajU4M25SMG95OHdlc1RHN1dmaHZZMF9uQ0o3R1FBa0NzQUtZMjIzMjU1bmttbGZsZUplQkd5Vmd2NEJoQ0NnbVhmVXppdWhiQkdpcGpQVFJVSHRBXy1pbnFJbXI0R2w3MmlvMEdCY2dGYVE4cWY2MENmeEp1ME9mZEFqSDVtdThTMk9kbUhIdXMtR0k?oc=5", "source_name": "Market source", "published_at": "2026-03-25T07:00:00+00:00", "published_display": "25 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Unpacking Q4 Earnings: Integer Holdings (NYSE:ITGR) In The Context Of Other Medical Devices & Supplies - Specialty Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMihAJBVV95cUxNdFRrRlJvM3J3cGJnVEJ6ZndqMnQxWkE4Wm8zTGtPTVc0OTlLN1pwNXIyclNJMFZkcG5qQTRTWThmNm9WN0hKYXBja3N3Y20zSlkxc2JaQlpYTnAyWnpvUVBvR1JWNmVxZGhSYVlYQklMd01GeFBVNGJWOFBWYUkwYmRrM2xrSktiQWpfTkZtNG1HWThNT0tqLUpYek5qcnFWMGE0QV9CaElrMUpfTEhnOC1pS2t1bkE2VVJHdEhWdEtoX2xKNE1MWk1OSlBSNTVZVU83WEpnb3E4aURwQ3ZyZUFDbndpTTZEa0lZRTJvU2VuTDhreXdCQ25iV3Y4YWxENm1xYQ?oc=5", "source_name": "StockStory", "published_at": "2026-03-16T07:00:00+00:00", "published_display": "16 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Q4 Earnings Highs And Lows: Abbott Laboratories (NYSE:ABT) Vs The Rest Of The Medical Devices & Supplies - Diversified Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMigAFBVV95cUxPeVpVN2I3X3lJNXd3TXJmRWV4X0RvRDdYR3l5a1k1SjMxUlhsWHdrUUNuZ1JIaUg4czdhZlA2VDVIallROFFuNmZXcnNzS1d3Vm0wS0tLMmlFVWdkUThsRDZYdTdZV3k3WkRjaUZSMUQ3dkRKYm5ZOVBjMVVBdTRjYQ?oc=5", "source_name": "Market source", "published_at": "2026-03-12T07:00:00+00:00", "published_display": "12 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Unpacking Q4 Earnings: Enovis (NYSE:ENOV) In The Context Of Other Medical Devices & Supplies - Specialty Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMihgFBVV95cUxNMzBPcXU1cnZKekZnaGlNVk05ZWFTWThNOS0tTlpvQjdaLVZIWlVXUk50NnVoQ0pPWWJpZUpWcVJyVDJMd2RJREVDbEEzTlU5UGhBbWtxWVEyVkdaMTVuNXZpaWFMNTZUQ2d0OW9Rc29kalJRY21naWlHZDBLS3RuZV9wdTdIUQ?oc=5", "source_name": "Market source", "published_at": "2026-03-10T07:00:00+00:00", "published_display": "10 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Q4 Earnings Highs And Lows: Baxter (NYSE:BAX) Vs The Rest Of The Medical Devices & Supplies - Diversified Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMigAFBVV95cUxOb3BiQVNFREdNblk2QS10b1lhRUtfb05vU2VFZHB5V0hJT0R4NmhwQWRrcFVsR3UwMjZleFV6N2FEelpZVzY3YWFxSWE1cWpLaTFrQVU4NktkQUloUkxaV3ZTVkh6b1ZmaDdMN2ViX1BUNE4xUTNUZFNlR0syVGlZSg?oc=5", "source_name": "Market source", "published_at": "2026-03-02T08:00:00+00:00", "published_display": "02 Mar 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}], "sector": []}, "total_fetched": 88, "total_relevant": 56, "sentiment_summary": {"positive": 4, "negative": 8, "neutral": 44, "score": 49, "total": 56, "label": "Balanced news tone", "tone": "neutral"}, "classifier": {"primary_event": "general", "primary_label": "Market update", "confidence": 79, "events": [{"event": "general", "label": "Market update", "weight": 15.95, "count": 29}, {"event": "earnings", "label": "Earnings", "weight": 11.49, "count": 23}, {"event": "analyst", "label": "Analyst action", "weight": 0.55, "count": 1}, {"event": "deals", "label": "Deals and strategy", "weight": 0.55, "count": 1}, {"event": "regulatory", "label": "Regulatory and legal", "weight": 0.55, "count": 1}, {"event": "guidance", "label": "Guidance", "weight": 0.55, "count": 1}], "positive_events": 4, "negative_events": 8}, "market_context": {"has_market_context": true, "latest_close": 5.32, "latest_week": "2026-07-10", "one_week_move": -2.4, "four_week_move": 3.7, "twelve_week_move": 30.1, "trend_signal": "0", "trend_label": "Trend inactive", "trend_tone": "negative", "market_dynamics": 0.642853, "market_dynamics_buy_signal": false, "relative_strength": -10.586115, "fair_value_gap": 10.9, "fair_value_label": "Near fair-value range", "fair_value_tone": "neutral", "expectation_direction": "undecided", "expectation_probability": 47.7545, "reaction_label": "Price reacting lower", "reaction_tone": "negative", "market_sentence": "-2.4% over one week, +3.7% over four weeks, trend inactive, and near fair-value range."}, "interpretation": {"label": "Balanced read", "tone": "neutral", "classification": "balanced", "summary": "News tone and price action are not far from neutral.", "confidence": 59, "badges": [], "opportunities": [], "risks": [], "event_label": "Market update", "sentiment_word": "balanced"}, "charts": {"sources": [{"label": "Stock Titan", "count": 13}, {"label": "Market source", "count": 10}, {"label": "Investing.com", "count": 5}, {"label": "TradingView", "count": 4}, {"label": "Investing.com South Africa", "count": 3}, {"label": "Investing.com Nigeria", "count": 2}, {"label": "Investing.com Canada", "count": 2}, {"label": "StockStory", "count": 2}], "tiers": [{"label": "Direct company coverage", "count": 45}, {"label": "Industry context", "count": 11}, {"label": "Sector context", "count": 0}], "events": [{"label": "Market update", "count": 29}, {"label": "Earnings", "count": 23}, {"label": "Analyst action", "count": 1}, {"label": "Deals and strategy", "count": 1}, {"label": "Regulatory and legal", "count": 1}, {"label": "Guidance", "count": 1}]}, "insights": [{"label": "Weighted tone", "value": "49/100", "tone": "neutral", "text": "Balanced news tone"}, {"label": "Market reaction", "value": "Balanced read", "tone": "neutral", "text": "News tone and price action are not far from neutral."}, {"label": "Primary event", "value": "Market update", "tone": "neutral", "text": "79/100 classification confidence."}, {"label": "Company focus", "value": "45", "tone": "positive", "text": "directly relevant articles"}, {"label": "Source quality", "value": "1", "tone": "positive", "text": "high-authority source matches"}, {"label": "Trend context", "value": "Trend inactive", "tone": "negative", "text": "-2.4% over one week, +3.7% over four weeks, trend inactive, and near fair-value range."}, {"label": "Latest direct headline", "value": "Negative", "tone": "negative", "text": "Have Insiders Sold Sight Sciences Shares Recently?"}], "updated_at": "2026-07-17T04:44:50.275852+00:00", "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}